IM-MV 24-002_000
|
Universitair Medisch Centrum Utrecht
|
Two clinical studies (Trials 1504-0001 and 1504-0003) with BI 3720931, a replication-deficient, self-inactivating, 3rd generation lentiviral vector gene therapy developed for inhaled treatment of cystic fibrosis
|
09-09-2024
|
Vergunning verleend
|